MGUS
8
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
European Myeloma Network (EMN) Sample Project
PROFAST Intervention in Precursor Multiple Myeloma
A Prospective Long-term Observational Study in Patients With Monoclonal Gammopathy of Undetermined Significance
Intestinal Flora and Immunity in Monoclonal Gammopathy Patients
Biology and Genetics of Smouldering Myeloma
Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients